2902 related articles for article (PubMed ID: 1710935)
1. Preparation and characterization of immunoconjugates for antibody-targeted photolysis.
Rakestraw SL; Tompkins RG; Yarmush ML
Bioconjug Chem; 1990; 1(3):212-21. PubMed ID: 1710935
[TBL] [Abstract][Full Text] [Related]
2. Antibody-targeted photolysis: in vitro studies with Sn(IV) chlorin e6 covalently bound to monoclonal antibodies using a modified dextran carrier.
Rakestraw SL; Tompkins RG; Yarmush ML
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4217-21. PubMed ID: 1693435
[TBL] [Abstract][Full Text] [Related]
3. Photocytotoxic action of EGF-PVA-Sn(IV)chlorin e6 and EGF-dextran-Sn(IV)chlorin e6 internalizable conjugates on A431 cells.
Gijsens A; De Witte P
Int J Oncol; 1998 Dec; 13(6):1171-7. PubMed ID: 9824627
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
Sinkule JA; Rosen ST; Radosevich JA
Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
[TBL] [Abstract][Full Text] [Related]
5. Antibody-targeted photolysis. Bacteriocidal effects of Sn (IV) chlorin e6-dextran-monoclonal antibody conjugates.
Friedberg JS; Tompkins RG; Rakestraw SL; Warren SW; Fischman AJ; Yarmush ML
Ann N Y Acad Sci; 1991; 618():383-93. PubMed ID: 1706578
[TBL] [Abstract][Full Text] [Related]
6. Antibody-targeted photolysis: in vitro immunological, photophysical, and cytotoxic properties of monoclonal antibody-dextran-Sn(IV) chlorin e6 immunoconjugates.
Rakestraw SL; Ford WE; Tompkins RG; Rodgers MA; Thorpe WP; Yarmush ML
Biotechnol Prog; 1992; 8(1):30-9. PubMed ID: 1371392
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of carbohydrate-linked murine monoclonal antibody K20-human serum albumin conjugates.
Kondejewski LH; Kralovec JA; Blair AH; Ghose T
Bioconjug Chem; 1994; 5(6):602-11. PubMed ID: 7873663
[TBL] [Abstract][Full Text] [Related]
8. Sn-chlorin e6 antibacterial immunoconjugates. An in vitro and in vivo analysis.
Lu XM; Fischman AJ; Stevens E; Lee TT; Strong L; Tompkins RG; Yarmush ML
J Immunol Methods; 1992 Nov; 156(1):85-99. PubMed ID: 1431166
[TBL] [Abstract][Full Text] [Related]
9. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
Kashmiri SV; Shu L; Padlan EA; Milenic DE; Schlom J; Hand PH
Hybridoma; 1995 Oct; 14(5):461-73. PubMed ID: 8575795
[TBL] [Abstract][Full Text] [Related]
10. Selective lethal photosensitization of methicillin-resistant Staphylococcus aureus using an IgG-tin (IV) chlorin e6 conjugate.
Embleton ML; Nair SP; Cookson BD; Wilson M
J Antimicrob Chemother; 2002 Dec; 50(6):857-64. PubMed ID: 12461004
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity.
Gijsens A; Missiaen L; Merlevede W; de Witte P
Cancer Res; 2000 Apr; 60(8):2197-202. PubMed ID: 10786684
[TBL] [Abstract][Full Text] [Related]
12. A novel heterobifunctional linker for formyl to thiol coupling.
Heindel ND; Zhao HR; Egolf RA; Chang CH; Schray KJ; Emrich JG; McLaughlin JP; Woo DV
Bioconjug Chem; 1991; 2(6):427-30. PubMed ID: 1725255
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-directed conjugation of cobra venom factor to antibody by selective derivatization of the terminal galactose residues.
Fu Q; Gowda DC
Bioconjug Chem; 2001; 12(2):271-9. PubMed ID: 11312689
[TBL] [Abstract][Full Text] [Related]
14. Preparation of immunoconjugates using antibody oligosaccharide moieties.
Vogel CW
Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
[TBL] [Abstract][Full Text] [Related]
15. [Targeting of chlorine E6 by EGF increasing its photodynamic activity in selective ways].
Gijsens A; De Witte P
Verh K Acad Geneeskd Belg; 2000; 62(4):329-52. PubMed ID: 11004908
[TBL] [Abstract][Full Text] [Related]
16. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
Trail PA; Willner D; Knipe J; Henderson AJ; Lasch SJ; Zoeckler ME; TrailSmith MD; Doyle TW; King HD; Casazza AM; Braslawsky GR; Brown J; Hofstead SJ; Greenfield RS; Firestone RA; Mosure K; Kadow KF; Yang MB; Hellström KE; Hellström I
Cancer Res; 1997 Jan; 57(1):100-5. PubMed ID: 8988048
[TBL] [Abstract][Full Text] [Related]
17. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
18. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
Greenfield RS; Kaneko T; Daues A; Edson MA; Fitzgerald KA; Olech LJ; Grattan JA; Spitalny GL; Braslawsky GR
Cancer Res; 1990 Oct; 50(20):6600-7. PubMed ID: 2208122
[TBL] [Abstract][Full Text] [Related]
19. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
King HD; Yurgaitis D; Willner D; Firestone RA; Yang MB; Lasch SJ; Hellström KE; Trail PA
Bioconjug Chem; 1999; 10(2):279-88. PubMed ID: 10077478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
